Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 Bacteria in Subjects With Lower Gastrointestinal Symptoms: a Prospective, Double-blinded, Randomized Controlled Clinical Trial

NCT07484412 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.

NCT NCT07484412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07484412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 Bacteria in Subjects With Lower Gastrointestinal Symptoms: a Prospective, Double-blinded, Randomized Controlled Clinical Trial
Lead sponsor
Seoul National University Bundang Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 1, 2025
Completion date
December 31, 2026
Enrollment
88 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea, irritable bowel syndrome, lower abdominal pain